Chugai Files NDA for Risdiplam as the First Oral Drug for Spinal Muscular Atrophy in Japan

Dear Investor, Please find attached a press release by Chugai:https://www.roche.com/201015_IR_Chugai_eRisdiplam_NDA.pdf Do not hesitate to contact us for any further questions. With best regards,
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news